Core Viewpoint - Abbott is set to finalize the acquisition of Exact Sciences on March 23, 2026, following the receipt of all necessary regulatory approvals, positioning the company to lead in the rapidly growing cancer screening and diagnostics market, thereby expanding its service to millions more individuals [1]. Group 1 - The acquisition of Exact Sciences will enable Abbott to enter and lead in the cancer screening and diagnostics segments [1]. - The transaction is expected to serve millions of additional people, indicating a significant market expansion for Abbott [1].